Crossmark

NAFLD is associated with less severe liver fibrosis in chronic hepatitis B: A multi-center, retrospective study

Crossref DOI link: https://doi.org/10.1016/j.aohep.2023.101155

Published Print: 2024-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Yao, Renling

Lu, Sufang

Xue, Ruifei

Wang, Jian

Qiu, Yuanwang

Chen, Yuxin

Liu, Jiacheng

Zhu, Li https://orcid.org/0000-0002-0953-5912
Zhan, Jie

Jiang, Suling

Yin, Shengxia

Tong, Xin

Ding, Weimao

Li, Jie

Zhu, Chuanwu

Huang, Rui

Wu, Chao
Funding

Funding for this research was provided by:

Natural Science Foundation of Jiangsu Province (BK20211004)

Nanjing University (2021-LCYJ-PY-43)

Medical Science and Technology Development Foundation, Nanjing Municipality Health Bureau (JQX21002)

Medical Science and Technology Development Foundation, Nanjing Municipality Health Bureau (QRX17121)

Medical Science and Technology Development Foundation, Nanjing Municipality Health Bureau (YKK20058)

Medical Science and Technology Development Foundation, Nanjing Municipality Health Bureau (YKK21067)
License Information

Text and Data Mining valid from 2024-01-01

Text and Data Mining valid from 2024-01-01

Version of Record valid from 2023-09-21
More Information

This article is maintained by: Elsevier

Article Title: NAFLD is associated with less severe liver fibrosis in chronic hepatitis B: A multi-center, retrospective study

Journal Title: Annals of Hepatology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.aohep.2023.101155

Content Type: article

Copyright: © 2023 Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U.